not tagged
not tagged
['head and neck']
improvement in overall survival for patients with locally advanced head and neck squamous cell carcinoma was demonstrated with xevinapant plus standard chemoradiotherapy vs matched placebo at the 5-year mark. #hancsm #esmo2022 | 
Oncology news and insights from leading researchers and cancer centers.